History of Childhood Sexual Abuse (CSA), Major Depressive Disorder (MDD)
Conditions
Keywords
Depression, Childhood Sexual Abuse, Dopamine, MRI, PET, ERP, Stress, Reward, Childhood trauma, Amisulpride
Brief summary
The purpose of this study is to investigate brain pathways within adult females (with a history of CSA that occurred between the ages of 5-14) with and without a current diagnosis of major depressive disorder (MDD). Hypotheses: The CSA/MDD participants will be characterized by (1) reduced reward responsiveness and prefrontal cortex activity, but increased cortisol levels, (2) reduced dopamine activity, and (3) reduced dopamine transporter binding. The over-arching purpose of the study is to (1) identify individuals at risk for psychopathology and maladaptive behavior, (2) prevent re-victimization, and (3) develop more targeted therapeutic interventions.
Detailed description
This study will include four sessions: Session 1 (SCID Session) The first session takes place at the Center for Depression, Anxiety, and Stress Research (CDASR) or Neuroimaging Center (both at McLean Hospital) and involves consenting, a clinical evaluation, a series of questionnaires, and a medical assessment. Session 2 or 3 (fMRI Session) The third session takes place at the Neuroimaging Center. Using a double-blind design, participants will be administered either amisulpride (50 mg) or placebo. Participants will complete the Monetary Incentive Delay (MID) task during functional magnetic resonance imaging (fMRI) and the Probabilistic Stimulus Selection Task (PSST) afterwards. Session 2 or 3 (PET Session) This session takes place at Massachusetts General Hospital. 9 mCi of \[11C\] altropane will be injected by a trained nuclear medicine technician and positron emission tomography (PET) scanning will begin. Prior to the PET scan, a blood serum pregnancy test will be administered for females. Session 4 (ERP Session) The fourth session takes place at the CDASR and involves an electroencephalography (EEG) recording, the Probabilistic Reward Task (PRT), and collecting saliva samples to assess cortisol levels.
Interventions
single low-dose pharmacological challenge, 50 mg amisulpride during the fMRI session only
single-dose placebo capsule during the fMRI session only
Sponsors
Study design
Intervention model description
There were four groups of subjects: those with a history of child sexual abuse that are currently experiencing a major depressive episode, those with a history of child sexual abuse without a current or past diagnosis of major depressive disorder, those without a history of child sexual abuse that are currently experiencing a major depressive episode, and those with without a history of child sexual abuse and without a current or past diagnosis of major depressive disorder. Within each group, half of the subjects were assigned to receive the study drug (amisulpride) and half to receive a placebo for the fMRI session (session 2 or 3).
Eligibility
Inclusion criteria
General Inclusion Criteria: * Females of all ethnic origins, age between 20 and 45; right-handed (Chapman & Chapman 1987); * Absence of any psychotropic medications for at least 2 weeks (6 weeks for fluoxetine; 6 months for neuroleptics; 2 weeks for benzodiazepines; 2 weeks for any other antidepressants); Inclusion Criteria for Childhood Sexual Abuse/MDD (CSA/MDD) Group: * At least one incident of contact sexual abuse1 between the ages 5-14 years; * Current DSM-IV diagnostic criteria for MDD (as diagnosed with the use of the SCID); Inclusion Criteria for Childhood Sexual Abuse/Resilient (CSA/RES) Group: * At least one incident of contact sexual abuse1 between the ages 5-14 years; * Absence of past or current DSM diagnosis, including MDD or alcohol/substance abuse; Inclusion Criteria for Non-traumatized, MDD (MDD) Group: * No incidents of sexual, verbal, or physical abuse (ascertained using the Traumatic Antecedents Questionnaire); * Current DSM-IV diagnostic criteria for MDD (as diagnosed with the use of SCID); Non-traumatized, healthy controls (controls): * No incidents of sexual, verbal, or physical abuse (ascertained using the Traumatic Antecedents Questionnaire); * Absence of any medical, neurological, and psychiatric illness (including alcohol/substance abuse)
Exclusion criteria
* Participants with suicidal ideation where study participation is deemed unsafe by the study clinician; * Pregnant women or women of childbearing potential who are not compliant with the requirements of a urine and blood pregnancy test. * Failure to meet MRI or PET safety requirements. * Serious or unstable medical illness, including cardiovascular, hepatic, renal, respiratory, endocrine (hypothyroidism), neurologic or hematologic disease; * Past/current DSM diagnosis of: OCD, ADHD, schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder, mood congruent/incongruent psychotic features, substance dependence, substance abuse within the last 12 months (with the exception of cocaine or stimulant abuse, which will lead to automatic exclusion); * Simple phobia, social anxiety disorder and generalized anxiety disorders will be allowed only if secondary to MDD and only in the CSA/MDD and MDD groups (which will be matched for comorbidities); * History of seizure disorder; renal insufficiency; history of adverse reactions to amisulpride; * History of cocaine, stimulant, and other DA drug use \[e.g., (meth)amphetamine), methylphenidate\].
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dopamine Active Transporter Binding Potential | 1 hour PET scan (Session 3) | Utilizing 11C-altropane during positron emission tomography (PET) scanning allows us to measure dopamine active transporter (DAT) binding potential. Our outcome measure is Nondisplacable Binding Potential (BPND). BPND refers to the ratio at equilibrium of specifically bound radioligand to that of nondisplaceable radioligand in tissue. \*Higher BPND scores indicate greater binding potential |
| The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | 3 hour EEG Session (Session 4) | The participant's performance on the Probabilistic Reward Task (PRT) was assessed both before and after an acute stressor. The PRT is a behavioral task that measures an individual's ability to learn from rewarding stimuli and incorporate this learning into their response style (response bias). The acute stressor was the Maastricht Acute Stress Test (MAST). The score obtained is a ratio of the number of times participants correctly choose the high reward stimuli versus the low rewarding stimuli. Response bias scores range between -1 and +1. Higher response bias scores indicate a stronger response bias toward high reward stimuli. A negative response bias indicates a stronger bias toward low reward stimuli. |
| The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | 3 hour EEG Session (Session 4) | EEG was recorded during the probabilistic reward task (the PRT task). Participants completed the Probabilistic Reward Task (PRT) twice throughout the experiment, once before stress and once after stress. The stressor was the Maastricht Acute Stress Test (MAST). This statistic shows the effect that childhood sexual abuse (CSA) and diagnosis had on a reward-related positivity EEG component recorded during the PRT, before and after stress. * Higher reward positivity amplitudes indicate a stronger neural response to reward and lower amplitudes indicate a lower neural response to rewards. |
| Cortisol Output in Response to a Stress Manipulation | 3 hour EEG Session (Session 4) | This statistic shows the impact of the stress manipulation on the participant's salivary cortisol output. Saliva samples were collected at 5 distinct time points throughout the study session. The first saliva sample (Cort 1) was collected when the participant began the eeg session. The second (Cort 2)was taken at the end of the acute stressor. The third (Cort 3) was taken approximately fifteen minutes after the second. The fourth (Cort 4) was taken approximately ten minutes after the third. The fifth (Cort 5) was taken approximately 40 minutes after the fourth. |
| Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | 3 hour Drug & fMRI Session (Session 2) | This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward cues during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation. |
| Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | 3 hour Session 2 (fMRI session) | This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward feedback during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation. |
| The Effect of Diagnosis on Cortisol Reactivity | 3 hour EEG Session (Session 4) | This is a measure of area under the curve in relation to ground, a measure of total cortisol output, in response to acute stress. The acute stressor was the Maastricht Acute Stress Test (MAST). The area under the curve includes all 5 cortisol measures, with one measure before the stressor and the other four measures collected after the stressor. Given that the cortisol data were positively skewed, the cortisol measures were normalized via a log transformation prior to calculating the area under the curve. Area under the curve with respect to ground (AUCG) is calculated AUC\_g=(((cort2\_log + cort1\_log) \* cort\_t1\_time) / 2)+(((cort3\_log+cort2\_log)\*cort\_t2\_time)/2)+(((cort4\_log+cort3\_log)\*cort\_t3\_time)/2)+(((cort5\_log+cort4\_log)\*cort\_t4\_time)/2). Cort\_logs are the log transformed cortisol output data (ng/ml) and the cort\_times are the time spans in between each cortisol assessment. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited at McLean Hospital (Belmont, MA) between August, 2013, and June, 2017. The study was advertised using flyers, and on a number of internet bulletin boards available to the general public. Study visits were conducted in research facilities at McLean Hospital and Massachusetts General Hospital.
Pre-assignment details
In session 1, subjects had a diagnostic interview, a physical exam, provided a blood sample, and completed surveys, to determine eligibility. Those eligible were invited to participate in the other sessions. Participants did not need to complete all sessions. The order depended on facility availability and convenience for participants.
Participants by arm
| Arm | Count |
|---|---|
| Control Group Subjects without a history of child sexual abuse and without a current or past diagnosis of major depressive episode. | 26 |
| MDD Group Subjects without a history of child sexual abuse that are currently experiencing a major depressive episode are randomized to receive a single low-dose pharmacological challenge. | 17 |
| CSA/RES Group Subjects with a history of CSA but no psychopathology (resilient group; CSA/RES). | 24 |
| CSA/MDD Group Subjects experiencing a current episode of major depression (MDD) with a history of child sexual abuse (CSA) are randomized to receive a single low-dose pharmacological challenge. | 29 |
| Total | 96 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 | FG004 | FG005 | FG006 | FG007 | FG008 | FG009 | FG010 | FG011 | FG012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assessment and Scheduling | Found to be Ineligible | 57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Assessment and Scheduling | Investigator Terminated | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Assessment and Scheduling | Lost to Follow-up | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Assessment and Scheduling | Withdrawal by Subject | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Baseline characteristics
| Characteristic | Control Group | MDD Group | CSA/RES Group | CSA/MDD Group | Total |
|---|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 26 Participants | 17 Participants | 24 Participants | 29 Participants | 96 Participants |
| Age, Continuous | 22.44 years STANDARD_DEVIATION 6.64 | 27.19 years STANDARD_DEVIATION 5.99 | 25.61 years STANDARD_DEVIATION 4.94 | 29.95 years STANDARD_DEVIATION 6.91 | 26.63 years STANDARD_DEVIATION 6.08 |
| BDI II | 1.68 units on a scale STANDARD_DEVIATION 2.79 | 27.23 units on a scale STANDARD_DEVIATION 8.44 | 3.83 units on a scale STANDARD_DEVIATION 5.77 | 31.49 units on a scale STANDARD_DEVIATION 9.05 | 15.95 units on a scale STANDARD_DEVIATION 15.14 |
| MASQ total | 93.04 units on a scale STANDARD_DEVIATION 16.27 | 167.86 units on a scale STANDARD_DEVIATION 22.6 | 101.82 units on a scale STANDARD_DEVIATION 26.19 | 180.57 units on a scale STANDARD_DEVIATION 21.89 | 135.42 units on a scale STANDARD_DEVIATION 44.65 |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 0 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) Asian | 2 Participants | 2 Participants | 0 Participants | 4 Participants | 8 Participants |
| Race (NIH/OMB) Black or African American | 3 Participants | 4 Participants | 9 Participants | 5 Participants | 21 Participants |
| Race (NIH/OMB) More than one race | 2 Participants | 0 Participants | 1 Participants | 5 Participants | 8 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 2 Participants | 2 Participants |
| Race (NIH/OMB) White | 18 Participants | 11 Participants | 14 Participants | 13 Participants | 56 Participants |
| Region of Enrollment United States | 26 Participants | 17 Participants | 24 Participants | 29 Participants | 96 Participants |
| Sex: Female, Male Female | 26 Participants | 17 Participants | 24 Participants | 29 Participants | 96 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk | EG004 affected / at risk | EG005 affected / at risk | EG006 affected / at risk | EG007 affected / at risk | EG008 affected / at risk | EG009 affected / at risk | EG010 affected / at risk | EG011 affected / at risk | EG012 affected / at risk | EG013 affected / at risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 153 | 0 / 96 | 0 / 26 | 0 / 11 | 0 / 11 | 0 / 17 | 0 / 9 | 0 / 8 | 0 / 24 | 0 / 6 | 0 / 6 | 0 / 29 | 0 / 10 | 0 / 7 |
| other Total, other adverse events | 0 / 153 | 0 / 96 | 0 / 26 | 0 / 11 | 0 / 11 | 0 / 17 | 0 / 9 | 0 / 8 | 0 / 24 | 0 / 6 | 0 / 6 | 0 / 29 | 0 / 10 | 0 / 7 |
| serious Total, serious adverse events | 0 / 153 | 0 / 96 | 0 / 26 | 0 / 11 | 0 / 11 | 0 / 17 | 0 / 9 | 0 / 8 | 0 / 24 | 0 / 6 | 0 / 6 | 0 / 29 | 0 / 10 | 0 / 7 |
Outcome results
Cortisol Output in Response to a Stress Manipulation
This statistic shows the impact of the stress manipulation on the participant's salivary cortisol output. Saliva samples were collected at 5 distinct time points throughout the study session. The first saliva sample (Cort 1) was collected when the participant began the eeg session. The second (Cort 2)was taken at the end of the acute stressor. The third (Cort 3) was taken approximately fifteen minutes after the second. The fourth (Cort 4) was taken approximately ten minutes after the third. The fifth (Cort 5) was taken approximately 40 minutes after the fourth.
Time frame: 3 hour EEG Session (Session 4)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | Cortisol Output in Response to a Stress Manipulation | Cort4 | 12.89 ng/ml | Standard Error 4.07 |
| Control Group | Cortisol Output in Response to a Stress Manipulation | Cort2 | 9.11 ng/ml | Standard Error 2.44 |
| Control Group | Cortisol Output in Response to a Stress Manipulation | Cort5 | 7.07 ng/ml | Standard Error 1.8 |
| Control Group | Cortisol Output in Response to a Stress Manipulation | Cort3 | 15.55 ng/ml | Standard Error 4.91 |
| Control Group | Cortisol Output in Response to a Stress Manipulation | Cort1 | 9.80 ng/ml | Standard Error 1.27 |
| MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort3 | 15.23 ng/ml | Standard Error 1.65 |
| MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort4 | 16.30 ng/ml | Standard Error 3.24 |
| MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort5 | 10.34 ng/ml | Standard Error 1.15 |
| MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort2 | 12.28 ng/ml | Standard Error 1.7 |
| MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort1 | 12.53 ng/ml | Standard Error 2.11 |
| CSA/RES Group | Cortisol Output in Response to a Stress Manipulation | Cort3 | 10.75 ng/ml | Standard Error 2.19 |
| CSA/RES Group | Cortisol Output in Response to a Stress Manipulation | Cort1 | 10.15 ng/ml | Standard Error 2.27 |
| CSA/RES Group | Cortisol Output in Response to a Stress Manipulation | Cort2 | 9.51 ng/ml | Standard Error 1.89 |
| CSA/RES Group | Cortisol Output in Response to a Stress Manipulation | Cort4 | 8.99 ng/ml | Standard Error 1.75 |
| CSA/RES Group | Cortisol Output in Response to a Stress Manipulation | Cort5 | 7.41 ng/ml | Standard Error 1.36 |
| CSA/MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort4 | 14.22 ng/ml | Standard Error 2.74 |
| CSA/MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort2 | 8.63 ng/ml | Standard Error 0.95 |
| CSA/MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort1 | 14.19 ng/ml | Standard Error 1.51 |
| CSA/MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort3 | 14.31 ng/ml | Standard Error 2.15 |
| CSA/MDD Group | Cortisol Output in Response to a Stress Manipulation | Cort5 | 11.01 ng/ml | Standard Error 2.15 |
Dopamine Active Transporter Binding Potential
Utilizing 11C-altropane during positron emission tomography (PET) scanning allows us to measure dopamine active transporter (DAT) binding potential. Our outcome measure is Nondisplacable Binding Potential (BPND). BPND refers to the ratio at equilibrium of specifically bound radioligand to that of nondisplaceable radioligand in tissue. \*Higher BPND scores indicate greater binding potential
Time frame: 1 hour PET scan (Session 3)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | Dopamine Active Transporter Binding Potential | Caudate | 3.191 Ratio | Standard Error 0.124 |
| Control Group | Dopamine Active Transporter Binding Potential | Accumbens | 2.159 Ratio | Standard Error 0.109 |
| Control Group | Dopamine Active Transporter Binding Potential | Putamen | 3.361 Ratio | Standard Error 0.12 |
| MDD Group | Dopamine Active Transporter Binding Potential | Accumbens | 2.103 Ratio | Standard Error 0.122 |
| MDD Group | Dopamine Active Transporter Binding Potential | Caudate | 3.161 Ratio | Standard Error 0.139 |
| MDD Group | Dopamine Active Transporter Binding Potential | Putamen | 3.359 Ratio | Standard Error 0.134 |
| CSA/RES Group | Dopamine Active Transporter Binding Potential | Putamen | 3.241 Ratio | Standard Error 0.125 |
| CSA/RES Group | Dopamine Active Transporter Binding Potential | Accumbens | 2.103 Ratio | Standard Error 0.122 |
| CSA/RES Group | Dopamine Active Transporter Binding Potential | Caudate | 3.175 Ratio | Standard Error 0.13 |
| CSA/MDD Group | Dopamine Active Transporter Binding Potential | Accumbens | 2.149 Ratio | Standard Error 0.119 |
| CSA/MDD Group | Dopamine Active Transporter Binding Potential | Putamen | 3.318 Ratio | Standard Error 0.131 |
| CSA/MDD Group | Dopamine Active Transporter Binding Potential | Caudate | 3.216 Ratio | Standard Error 0.136 |
Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues
This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward cues during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.
Time frame: 3 hour Drug & fMRI Session (Session 2)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | .385 beta weight (slope) | Standard Error 0.173 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .514 beta weight (slope) | Standard Error 0.199 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .254 beta weight (slope) | Standard Error 0.161 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .550 beta weight (slope) | Standard Error 0.175 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .692 beta weight (slope) | Standard Error 0.206 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .550 beta weight (slope) | Standard Error 0.175 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .468 beta weight (slope) | Standard Error 0.209 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .054 beta weight (slope) | Standard Error 0.238 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .357 beta weight (slope) | Standard Error 0.168 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | .040 beta weight (slope) | Standard Error 0.207 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | -.243 beta weight (slope) | Standard Error 0.192 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .255 beta weight (slope) | Standard Error 0.247 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .679 beta weight (slope) | Standard Error 0.267 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .745 beta weight (slope) | Standard Error 0.226 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .050 beta weight (slope) | Standard Error 0.208 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .493 beta weight (slope) | Standard Error 0.181 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | -.123 beta weight (slope) | Standard Error 0.224 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .511 beta weight (slope) | Standard Error 0.257 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .310 beta weight (slope) | Standard Error 0.267 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .079 beta weight (slope) | Standard Error 0.257 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | -.370 beta weight (slope) | Standard Error 0.208 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .419 beta weight (slope) | Standard Error 0.226 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .240 beta weight (slope) | Standard Error 0.181 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | -.381 beta weight (slope) | Standard Error 0.224 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .351 beta weight (slope) | Standard Error 0.218 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .047 beta weight (slope) | Standard Error 0.17 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | -.111 beta weight (slope) | Standard Error 0.183 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .403 beta weight (slope) | Standard Error 0.209 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .384 beta weight (slope) | Standard Error 0.148 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .698 beta weight (slope) | Standard Error 0.185 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .814 beta weight (slope) | Standard Error 0.196 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .621 beta weight (slope) | Standard Error 0.157 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .156 beta weight (slope) | Standard Error 0.18 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .428 beta weight (slope) | Standard Error 0.231 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .608 beta weight (slope) | Standard Error 0.222 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | .140 beta weight (slope) | Standard Error 0.194 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .455 beta weight (slope) | Standard Error 0.134 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .401 beta weight (slope) | Standard Error 0.197 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .200 beta weight (slope) | Standard Error 0.189 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .608 beta weight (slope) | Standard Error 0.162 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | .016 beta weight (slope) | Standard Error 0.165 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .222 beta weight (slope) | Standard Error 0.154 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Neutral Cues | .518 beta weight (slope) | Standard Error 0.134 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Putamen Response to Reward Cues | .663 beta weight (slope) | Standard Error 0.167 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Neutral Cues | .120 beta weight (slope) | Standard Error 0.165 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Accumbens Response to Reward Cues | .480 beta weight (slope) | Standard Error 0.197 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Reward Cues | .468 beta weight (slope) | Standard Error 0.189 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues | Caudate Response to Neutral Cues | .185 beta weight (slope) | Standard Error 0.154 |
Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback
This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward feedback during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.
Time frame: 3 hour Session 2 (fMRI session)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | .010 beta weight (slope) | Standard Error 0.308 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.101 beta weight (slope) | Standard Error 0.329 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.233 beta weight (slope) | Standard Error 0.314 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.018 beta weight (slope) | Standard Error 0.217 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | -.158 beta weight (slope) | Standard Error 0.421 |
| Control Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.021 beta weight (slope) | Standard Error 0.201 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | .063 beta weight (slope) | Standard Error 0.26 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | .040 beta weight (slope) | Standard Error 0.393 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.418 beta weight (slope) | Standard Error 0.24 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.332 beta weight (slope) | Standard Error 0.368 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.608 beta weight (slope) | Standard Error 0.376 |
| MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | .839 beta weight (slope) | Standard Error 0.503 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | -.046 beta weight (slope) | Standard Error 0.544 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.087 beta weight (slope) | Standard Error 0.281 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.501 beta weight (slope) | Standard Error 0.406 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.142 beta weight (slope) | Standard Error 0.26 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.079 beta weight (slope) | Standard Error 0.398 |
| CSA/RES Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.197 beta weight (slope) | Standard Error 0.425 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | -.713 beta weight (slope) | Standard Error 0.544 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.905 beta weight (slope) | Standard Error 0.425 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.959 beta weight (slope) | Standard Error 0.406 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.304 beta weight (slope) | Standard Error 0.281 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.276 beta weight (slope) | Standard Error 0.26 |
| CSA/MDD Group | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.819 beta weight (slope) | Standard Error 0.398 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | -.554 beta weight (slope) | Standard Error 0.444 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.865 beta weight (slope) | Standard Error 0.331 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.456 beta weight (slope) | Standard Error 0.325 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.819 beta weight (slope) | Standard Error 0.347 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.229 beta weight (slope) | Standard Error 0.221 |
| MDD-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.031 beta weight (slope) | Standard Error 0.229 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.357 beta weight (slope) | Standard Error 0.243 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.108 beta weight (slope) | Standard Error 0.225 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.733 beta weight (slope) | Standard Error 0.352 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | -.215 beta weight (slope) | Standard Error 0.471 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.773 beta weight (slope) | Standard Error 0.368 |
| MDD-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.039 beta weight (slope) | Standard Error 0.345 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | -.375 beta weight (slope) | Standard Error 0.192 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | .074 beta weight (slope) | Standard Error 0.401 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.613 beta weight (slope) | Standard Error 0.314 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.533 beta weight (slope) | Standard Error 0.207 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | -.503 beta weight (slope) | Standard Error 0.294 |
| Control-amisulpride | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.793 beta weight (slope) | Standard Error 0.3 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Neutral Feedback | .164 beta weight (slope) | Standard Error 0.192 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Putamen Response to Reward Feedback | -.131 beta weight (slope) | Standard Error 0.207 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Neutral Feedback | .109 beta weight (slope) | Standard Error 0.294 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Accumbens Response to Reward Feedback | .069 beta weight (slope) | Standard Error 0.401 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Reward Feedback | -.273 beta weight (slope) | Standard Error 0.314 |
| Control-placebo | Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback | Caudate Response to Neutral Feedback | -.105 beta weight (slope) | Standard Error 0.3 |
The Effect of Diagnosis on Cortisol Reactivity
This is a measure of area under the curve in relation to ground, a measure of total cortisol output, in response to acute stress. The acute stressor was the Maastricht Acute Stress Test (MAST). The area under the curve includes all 5 cortisol measures, with one measure before the stressor and the other four measures collected after the stressor. Given that the cortisol data were positively skewed, the cortisol measures were normalized via a log transformation prior to calculating the area under the curve. Area under the curve with respect to ground (AUCG) is calculated AUC\_g=(((cort2\_log + cort1\_log) \* cort\_t1\_time) / 2)+(((cort3\_log+cort2\_log)\*cort\_t2\_time)/2)+(((cort4\_log+cort3\_log)\*cort\_t3\_time)/2)+(((cort5\_log+cort4\_log)\*cort\_t4\_time)/2). Cort\_logs are the log transformed cortisol output data (ng/ml) and the cort\_times are the time spans in between each cortisol assessment.
Time frame: 3 hour EEG Session (Session 4)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control Group | The Effect of Diagnosis on Cortisol Reactivity | 156.58 [log (ng/ml)]*min | Standard Error 10.72 |
| MDD Group | The Effect of Diagnosis on Cortisol Reactivity | 186.78 [log (ng/ml)]*min | Standard Error 12.2 |
| CSA/RES Group | The Effect of Diagnosis on Cortisol Reactivity | 152.13 [log (ng/ml)]*min | Standard Error 12.2 |
| CSA/MDD Group | The Effect of Diagnosis on Cortisol Reactivity | 179.16 [log (ng/ml)]*min | Standard Error 11.25 |
The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress
EEG was recorded during the probabilistic reward task (the PRT task). Participants completed the Probabilistic Reward Task (PRT) twice throughout the experiment, once before stress and once after stress. The stressor was the Maastricht Acute Stress Test (MAST). This statistic shows the effect that childhood sexual abuse (CSA) and diagnosis had on a reward-related positivity EEG component recorded during the PRT, before and after stress. * Higher reward positivity amplitudes indicate a stronger neural response to reward and lower amplitudes indicate a lower neural response to rewards.
Time frame: 3 hour EEG Session (Session 4)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Pre MAST | 2.71 amplitude (microvolts) | Standard Error 0.86 |
| Control Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Post MAST | 2.06 amplitude (microvolts) | Standard Error 0.91 |
| MDD Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Post MAST | 4.99 amplitude (microvolts) | Standard Error 1.22 |
| MDD Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Pre MAST | 4.75 amplitude (microvolts) | Standard Error 1.15 |
| CSA/RES Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Pre MAST | 2.16 amplitude (microvolts) | Standard Error 0.92 |
| CSA/RES Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Post MAST | 2.30 amplitude (microvolts) | Standard Error 0.98 |
| CSA/MDD Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Pre MAST | 4.15 amplitude (microvolts) | Standard Error 0.96 |
| CSA/MDD Group | The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress | Post MAST | 3.90 amplitude (microvolts) | Standard Error 1.01 |
The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress
The participant's performance on the Probabilistic Reward Task (PRT) was assessed both before and after an acute stressor. The PRT is a behavioral task that measures an individual's ability to learn from rewarding stimuli and incorporate this learning into their response style (response bias). The acute stressor was the Maastricht Acute Stress Test (MAST). The score obtained is a ratio of the number of times participants correctly choose the high reward stimuli versus the low rewarding stimuli. Response bias scores range between -1 and +1. Higher response bias scores indicate a stronger response bias toward high reward stimuli. A negative response bias indicates a stronger bias toward low reward stimuli.
Time frame: 3 hour EEG Session (Session 4)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: Before MAST | 0.028 Ratio (Response Bias Score) | Standard Deviation 0.035 |
| Control Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: Before MAST | 0.124 Ratio (Response Bias Score) | Standard Deviation 0.046 |
| Control Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: After MAST | 0.128 Ratio (Response Bias Score) | Standard Deviation 0.026 |
| Control Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: After MAST | 0.245 Ratio (Response Bias Score) | Standard Deviation 0.041 |
| MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: Before MAST | 0.155 Ratio (Response Bias Score) | Standard Deviation 0.048 |
| MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: After MAST | 0.078 Ratio (Response Bias Score) | Standard Deviation 0.055 |
| MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: After MAST | 0.128 Ratio (Response Bias Score) | Standard Deviation 0.035 |
| MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: Before MAST | 0.117 Ratio (Response Bias Score) | Standard Deviation 0.045 |
| CSA/RES Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: After MAST | 0.079 Ratio (Response Bias Score) | Standard Deviation 0.042 |
| CSA/RES Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: Before MAST | 0.130 Ratio (Response Bias Score) | Standard Deviation 0.082 |
| CSA/RES Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: After MAST | 0.143 Ratio (Response Bias Score) | Standard Deviation 0.052 |
| CSA/RES Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: Before MAST | 0.092 Ratio (Response Bias Score) | Standard Deviation 0.043 |
| CSA/MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: After MAST | 0.127 Ratio (Response Bias Score) | Standard Deviation 0.05 |
| CSA/MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block2: Before MAST | 0.168 Ratio (Response Bias Score) | Standard Deviation 0.102 |
| CSA/MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: Before MAST | 0.167 Ratio (Response Bias Score) | Standard Deviation 0.07 |
| CSA/MDD Group | The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress | PRT Block1: After MAST | 0.048 Ratio (Response Bias Score) | Standard Deviation 0.042 |